iPSC motor neurons, but not other derived cell types, capture gene expression changes in postmortem sporadic ALS motor neurons.

ALS CP: Neuroscience CP: Stem cell research TDP-43 cell-type specificity disease modeling nonsense-mediated decay splicing

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
26 09 2023
Historique:
received: 27 09 2022
revised: 10 05 2023
accepted: 11 08 2023
medline: 5 10 2023
pubmed: 31 8 2023
entrez: 31 8 2023
Statut: ppublish

Résumé

Motor neuron degeneration, the defining feature of amyotrophic lateral sclerosis (ALS), is a primary example of cell-type specificity in neurodegenerative diseases. Using isogenic pairs of induced pluripotent stem cells (iPSCs) harboring different familial ALS mutations, we assess the capacity of iPSC-derived lower motor neurons, sensory neurons, astrocytes, and superficial cortical neurons to capture disease features including transcriptional and splicing dysregulation observed in human postmortem neurons. At early time points, differentially regulated genes in iPSC-derived lower motor neurons, but not other cell types, overlap with one-third of the differentially regulated genes in laser-dissected motor neurons from ALS compared with control postmortem spinal cords. For genes altered in both the iPSC model and bona fide human lower motor neurons, expression changes correlate between the two populations. In iPSC-derived lower motor neurons, but not other derived cell types, we detect the downregulation of genes affected by TDP-43-dependent splicing. This reduction takes place exclusively within genotypes known to involve TDP-43 pathology.

Identifiants

pubmed: 37651231
pii: S2211-1247(23)01057-4
doi: 10.1016/j.celrep.2023.113046
pmc: PMC10622181
mid: NIHMS1933889
pii:
doi:

Substances chimiques

DNA-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

113046

Subventions

Organisme : NINDS NIH HHS
ID : RF1 NS127407
Pays : United States
Organisme : NINDS NIH HHS
ID : RF1 NS124203
Pays : United States
Organisme : NINDS NIH HHS
ID : DP2 NS106664
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS112503
Pays : United States
Organisme : NINDS NIH HHS
ID : F32 NS114319
Pays : United States

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests B.J.W. is a consultant and member of the scientific advisory board of Quralis and is a coinventor on patent US9517223B2, issued for use of potassium channel openers in neurodegenerative diseases.

Références

Neuron. 2011 Oct 20;72(2):257-68
pubmed: 21944779
Nat Commun. 2015 Sep 24;6:8390
pubmed: 26399630
JAMA Neurol. 2021 Feb 1;78(2):186-196
pubmed: 33226425
Cell. 2023 Feb 16;186(4):786-802.e28
pubmed: 36754049
Science. 2008 Mar 21;319(5870):1668-72
pubmed: 18309045
Nat Commun. 2022 Jun 23;13(1):3306
pubmed: 35739092
Bioinformatics. 2018 Jan 15;34(2):300-302
pubmed: 28968636
Science. 2006 Oct 6;314(5796):130-3
pubmed: 17023659
Neuron. 2023 Apr 19;111(8):1191-1204.e5
pubmed: 36764301
Sci Transl Med. 2021 Jul 7;13(601):
pubmed: 34233951
Ann Neurol. 2008 Jul;64(1):60-70
pubmed: 18546284
Brain Res. 2017 Feb 1;1656:88-97
pubmed: 26462653
Cell Stem Cell. 2023 Feb 2;30(2):171-187.e14
pubmed: 36736291
Acta Neuropathol. 2015 Nov;130(5):643-60
pubmed: 26197969
Nat Neurosci. 2019 Feb;22(2):180-190
pubmed: 30643298
Ann Neurol. 2020 Oct;88(4):796-806
pubmed: 32627229
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Nature. 2022 Mar;603(7899):124-130
pubmed: 35197626
Nat Med. 2018 Mar;24(3):313-325
pubmed: 29400714
N Engl J Med. 2017 Jul 13;377(2):162-172
pubmed: 28700839
Genome Biol. 2014;15(12):550
pubmed: 25516281
Elife. 2017 Oct 09;6:
pubmed: 28990928
Nature. 2012 Aug 23;488(7412):499-503
pubmed: 22801503
Neuron. 2013 Jun 5;78(5):785-98
pubmed: 23764284
Nat Methods. 2021 May;18(5):528-541
pubmed: 33941937
Am J Pathol. 2007 Jul;171(1):227-40
pubmed: 17591968
Mol Neurodegener. 2017 Feb 2;12(1):13
pubmed: 28153034
Nat Med. 2018 Oct;24(10):1579-1589
pubmed: 30127392
Nat Commun. 2019 Nov 29;10(1):5466
pubmed: 31784536
Nature. 2022 Mar;603(7899):131-137
pubmed: 35197628
Neuron. 2011 Oct 20;72(2):245-56
pubmed: 21944778
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Science. 2019 Feb 15;363(6428):
pubmed: 30765536
Nat Protoc. 2017 Jun;12(6):1198-1228
pubmed: 28518172
Front Mol Neurosci. 2019 Feb 14;12:25
pubmed: 30837838
Nat Neurosci. 2013 Sep;16(9):1219-27
pubmed: 23872598
Cell Rep. 2019 Apr 30;27(5):1409-1421.e6
pubmed: 31042469
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Acta Neuropathol. 2018 Sep;136(3):405-423
pubmed: 29881994
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E736-45
pubmed: 23382207
Nat Commun. 2021 Aug 6;12(1):4744
pubmed: 34362895
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Science. 2015 Aug 7;349(6248):650-5
pubmed: 26250685
Neurobiol Dis. 2020 Feb;134:104680
pubmed: 31759135
Stem Cell Reports. 2017 Aug 8;9(2):600-614
pubmed: 28757165
Nat Commun. 2020 Jul 3;11(1):3354
pubmed: 32620797
J Biol Chem. 2016 Nov 4;291(45):23464-23476
pubmed: 27634045
Nat Rev Neurol. 2017 Feb;13(2):96-104
pubmed: 27982040
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Neuropathol Exp Neurol. 1981 Nov;40(6):667-75
pubmed: 7299423
Mol Psychiatry. 2012 Nov;17(11):1103-15
pubmed: 22182939
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Cell Rep. 2020 Jan 21;30(3):932-946.e7
pubmed: 31968264
Stem Cell Reports. 2020 Mar 10;14(3):390-405
pubmed: 32084385
Nat Neurosci. 2019 Feb;22(2):167-179
pubmed: 30643292
Nat Genet. 2004 Oct;36(10):1073-8
pubmed: 15448691
Curr Opin Struct Biol. 2020 Dec;65:110-118
pubmed: 32688260
Mol Cell Biol. 2006 Feb;26(4):1272-87
pubmed: 16449641
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1531-6
pubmed: 21205896
eNeuro. 2022 Jun 8;9(3):
pubmed: 35641224
Ann Neurol. 2007 May;61(5):427-34
pubmed: 17469116
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Cell Stem Cell. 2014 Jun 5;14(6):781-95
pubmed: 24704492
Neurotherapeutics. 2017 Jan;14(1):78-90
pubmed: 27878516
Neuron. 2022 Mar 16;110(6):992-1008.e11
pubmed: 35045337

Auteurs

Aaron Held (A)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Michelle Adler (M)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Christine Marques (C)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Charles Jourdan Reyes (CJ)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; The Collaborative Center for X-Linked Dystonia-Parkinsonism, Department of Neurology, Massachusetts General Hospital, Charlestown, MA 02129, USA.

Amey S Kavuturu (AS)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Ana R A A Quadros (ARAA)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

I Sandra Ndayambaje (IS)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Erika Lara (E)

iPSC Neurodegenerative Research Initiative, Center for Alzheimer's and Related Dementias, National Institute on Aging, NIH, Bethesda, MD 20892, USA.

Michael Ward (M)

National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA.

Clotilde Lagier-Tourenne (C)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard University and MIT, Cambridge MA 02142, USA.

Brian J Wainger (BJ)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard University and MIT, Cambridge MA 02142, USA; Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston MA 02114, USA; Harvard Stem Cell Institute, Cambridge MA 02138, USA. Electronic address: brian.wainger@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH